Molecular Diagnostics Market: Fluidigm & Ascendas Genomoics Form MDx Pact in China

1
Molecular Diagnostics Market Pleased With Agilent
Technologies Introduction of Real-time PCR
System in Europe
By Products (Analyzers, Reagents) Technology
(PCR, INAAT, Hybridization, DNA Sequencing
Others) End Users (Hospitals, Clinical
Laboratories, Academics) Applications (Oncology,
Microbiology, Others)-Forecast (2017-2022)


2

• The Molecular Diagnostics Market deals with the
  development and advancement of diagnostic tests
  which help in identifying specific sequences
  within DNA or RNA samples. Such molecular testing
  methods help in the accurate diagnosis of
  diseases and to assess the liability of a disease
  affecting an individuals DNA.
• Molecular diagnostics has undergone a massive
  revolution over the last couple of decades. The
  Molecular Diagnostics Market is the main thrust
  behind the present change in medical services,
  prompting major leaps in knowledge in the field
  of genetic testing as well as biology at the
  molecular level. These developments encompass
  advanced molecular diagnostics which help in
  identifying cancer at an early stage,
  cutting-edge DNA sequencing, microarray
  technologies, etc.

3

• Scope Regional Forecast of the Molecular
  Diagnostics Market
• Variables like rising reports of infections and
  cancer, improvement in awareness regarding
  molecular diagnostic testing, widespread
  availability of customized medicines, and various
  technical leaps made in biomarker testing are the
  key growth drivers of the Molecular Diagnostics
  Market. On the other hand, the great difficulty
  with which molecular diagnostics companies gain
  approval for testing new techniques hampers the
  development of the market.
• Currently, the North American region holds the
  highest share in the Molecular Diagnostics
  Market, largely due to variables like the growing
  numbers of the aged or elderly, more cases of
  infections and chronic issues being reported, and
  more public preference for personalized
  medication. The European segment of the Molecular
  Diagnostics Market is the second largest region
  due to the presence of an advanced healthcare
  system and implementation of sound policies.

Request For Toc
4

• Segmentations Key Players Involved in the
  Molecular Diagnostics Market
• Products Analyzers and Reagents.
• Technology PCR, INAAT, Hybridization, DNA
  Sequencing and Next Generation Sequencing,
  Microarray, Spectral Karyotype Imaging (SKI) and
  Others.
• End-Users Hospitals, Clinical Laboratories and
  Academics.
• Applications Infectious Disease (HBV, HCV, HIV,
  TB, CT/NG, HPV, MRSA, Others), Oncology (Prostate
  Cancer, Breast Cancer, Colorectal Cancer,
  Others), Genetic Disease Screening, Blood
  Screening, Microbiology and Others.
• Geography Americas, Europe, Asia-Pacific and
  Rest of the World.

5

• Some of the key players involved in the Molecular
  Diagnostics Market are as follows
• Johnson and Johnson
• Bayer Healthcare AG
• Alere Inc.
• Leica Biosystems
• Agilient Technologies, Inc

Inquiry Before Purchase
6
You Can Customize the Report as Per Your Need. We
have included Some Customization Options
Company Profile
Analyst Briefing
Data Tables
Key Contacts
Customization
Purchase Full Report
7
About IndustryARC
IndustryARC is a Research and consulting firm
that publishes more than 500 Reports Annually in
various industries, such as Agriculture,
Automotive, Automation Instrumentation,
Chemicals and Materials, Energy and Power,
Electronics, Food Beverages, Information
Technology, Life sciences Healthcare. IndustryA
RC primarily focuses on Cutting Edge Technologies
and Newer Applications of the Market. Our Custom
Research Services are designed to provide
insights on the constant flux in the global
demand-supply gap of markets. Our strong analyst
team enables us to meet the client research needs
at a very quick speed with a variety of options
for your business.